Mast cell activation enhances airway responsiveness to methacholine in the mouse.
Journal: 1993/April - Journal of Clinical Investigation
ISSN: 0021-9738
Abstract:
Mast cell-deficient mutant mice and their normal littermates were used to determine whether activation of mast cells by anti-IgE enhances airway responsiveness to bronchoactive agonists in vivo. Pulmonary conductance was used as an index of airway response as the mice were challenged with increasing intravenous doses of methacholine (Mch) or 5-hydroxytryptamine (5-HT). Mast cell activation with anti-IgE enhanced pulmonary responsiveness to Mch in both types of normal mice (P < 0.0001 by analysis of variance) but not in either genotype of mast cell-deficient mouse. Additionally, anti-IgE pretreatment of genetically mast cell-deficient W/Wv mice whose mast cell deficiency had been repaired by infusion of freshly obtained bone marrow cells or bone marrow-derived cultured mast cells from congenic normal mice led to significant (P < 0.0001) enhancement of Mch responsiveness. 5-HT responsiveness was not significantly influenced by anti-IgE pretreatment in any of the mice studied. The data support the hypothesis that IgE-mediated activation of mast cells enhances pulmonary responsiveness to cholinergic stimulation.
Relations:
Content
Citations
(21)
References
(39)
Grants
(193)
Chemicals
(4)
Organisms
(4)
Processes
(2)
Anatomy
(2)
Similar articles
Articles by the same authors
Discussion board
J Clin Invest 91(3): 1176-1182

Mast cell activation enhances airway responsiveness to methacholine in the mouse.

Abstract

Mast cell-deficient mutant mice and their normal littermates were used to determine whether activation of mast cells by anti-IgE enhances airway responsiveness to bronchoactive agonists in vivo. Pulmonary conductance was used as an index of airway response as the mice were challenged with increasing intravenous doses of methacholine (Mch) or 5-hydroxytryptamine (5-HT). Mast cell activation with anti-IgE enhanced pulmonary responsiveness to Mch in both types of normal mice (P < 0.0001 by analysis of variance) but not in either genotype of mast cell-deficient mouse. Additionally, anti-IgE pretreatment of genetically mast cell-deficient W/Wv mice whose mast cell deficiency had been repaired by infusion of freshly obtained bone marrow cells or bone marrow-derived cultured mast cells from congenic normal mice led to significant (P < 0.0001) enhancement of Mch responsiveness. 5-HT responsiveness was not significantly influenced by anti-IgE pretreatment in any of the mice studied. The data support the hypothesis that IgE-mediated activation of mast cells enhances pulmonary responsiveness to cholinergic stimulation.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Curry JJ. THE ACTION OF HISTAMINE ON THE RESPIRATORY TRACT IN NORMAL AND ASTHMATIC SUBJECTS. J Clin Invest. 1946 Nov;25(6):785–791.[PMC free article] [PubMed] [Google Scholar]
  • Pattemore PK, Asher MI, Harrison AC, Mitchell EA, Rea HH, Stewart AW. The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms. Am Rev Respir Dis. 1990 Sep;142(3):549–554. [PubMed] [Google Scholar]
  • Fish JE, Rosenthal RR, Batra G, Menkes H, Summer W, Permutt S, Norman P. Airway responses to methacholine in allergic and nonallergic subjects. Am Rev Respir Dis. 1976 May;113(5):579–586. [PubMed] [Google Scholar]
  • Schleimer RP, MacGlashan DW, Jr, Peters SP, Pinckard RN, Adkinson NF, Jr, Lichtenstein LM. Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis. 1986 Apr;133(4):614–617. [PubMed] [Google Scholar]
  • Mencia-Huerta JM, Lewis RA, Razin E, Austen KF. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. J Immunol. 1983 Dec;131(6):2958–2964. [PubMed] [Google Scholar]
  • Cuss FM, Dixon CM, Barnes PJ. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet. 1986 Jul 26;2(8500):189–192. [PubMed] [Google Scholar]
  • Arm JP, Spur BW, Lee TH. The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects. J Allergy Clin Immunol. 1988 Oct;82(4):654–660. [PubMed] [Google Scholar]
  • Weiss EB, Bellino JR. Leukotriene-associated toxic oxygen metabolites induce airway hyperreactivity. Chest. 1986 May;89(5):709–716. [PubMed] [Google Scholar]
  • O'Byrne PM, Leikauf GD, Aizawa H, Bethel RA, Ueki IF, Holtzman MJ, Nadel JA. Leukotriene B4 induces airway hyperresponsiveness in dogs. J Appl Physiol (1985) 1985 Dec;59(6):1941–1946. [PubMed] [Google Scholar]
  • Chung KF, Aizawa H, Becker AB, Frick O, Gold WM, Nadel JA. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs. Am Rev Respir Dis. 1986 Aug;134(2):258–261. [PubMed] [Google Scholar]
  • O'Byrne PM, Aizawa H, Bethel RA, Chung KF, Nadel JA, Holtzman MJ. Prostaglandin F2 alpha increases responsiveness of pulmonary airways in dogs. Prostaglandins. 1984 Oct;28(4):537–543. [PubMed] [Google Scholar]
  • Sekizawa K, Caughey GH, Lazarus SC, Gold WM, Nadel JA. Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs. J Clin Invest. 1989 Jan;83(1):175–179.[PMC free article] [PubMed] [Google Scholar]
  • Marone G, Casolaro V, Cirillo R, Stellato C, Genovese A. Pathophysiology of human basophils and mast cells in allergic disorders. Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 2):S24–S40. [PubMed] [Google Scholar]
  • Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AM, Schwartz LB, Durham SR, Jeffery PK, Kay AB. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol. 1991 Oct;88(4):661–674. [PubMed] [Google Scholar]
  • Rankin JA, Hitchcock M, Merrill WW, Huang SS, Brashler JR, Bach MK, Askenase PW. IgE immune complexes induce immediate and prolonged release of leukotriene C4 (LTC4) from rat alveolar macrophages. J Immunol. 1984 Apr;132(4):1993–1999. [PubMed] [Google Scholar]
  • Rankin JA, Hitchcock M, Merrill W, Bach MK, Brashler JR, Askenase PW. IgE-dependent release of leukotriene C4 from alveolar macrophages. Nature. 1982 May 27;297(5864):329–331. [PubMed] [Google Scholar]
  • Owen WF, Jr, Soberman RJ, Yoshimoto T, Sheffer AL, Lewis RA, Austen KF. Synthesis and release of leukotriene C4 by human eosinophils. J Immunol. 1987 Jan 15;138(2):532–538. [PubMed] [Google Scholar]
  • Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood. 1978 Aug;52(2):447–452. [PubMed] [Google Scholar]
  • Galli SJ, Kitamura Y. Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathol. 1987 Apr;127(1):191–198.[PMC free article] [PubMed] [Google Scholar]
  • Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature. 1988 Sep 1;335(6185):88–89. [PubMed] [Google Scholar]
  • Geissler EN, Ryan MA, Housman DE. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell. 1988 Oct 7;55(1):185–192. [PubMed] [Google Scholar]
  • Nakano T, Sonoda T, Hayashi C, Yamatodani A, Kanayama Y, Yamamura T, Asai H, Yonezawa T, Kitamura Y, Galli SJ. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med. 1985 Sep 1;162(3):1025–1043.[PMC free article] [PubMed] [Google Scholar]
  • Baniyash M, Eshhar Z. Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE. Eur J Immunol. 1984 Sep;14(9):799–807. [PubMed] [Google Scholar]
  • Martin TR, Gerard NP, Galli SJ, Drazen JM. Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol (1985) 1988 Jun;64(6):2318–2323. [PubMed] [Google Scholar]
  • Kroeker JP. Wiener analysis of nonlinear systems using Poisson-Charlier crosscorrelation. Biol Cybern. 1977 Oct 14;27(4):221–227. [PubMed] [Google Scholar]
  • Dvorak HF, Mihm MC, Jr, Dvorak AM, Barnes BA, Manseau EJ, Galli SJ. Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med. 1979 Aug 1;150(2):322–337.[PMC free article] [PubMed] [Google Scholar]
  • Galli SJ, Wershil BK, Bose R, Walker PA, Szabo S. Ethanol-induced acute gastric injury in mast cell-deficient and congenic normal mice. Evidence that mast cells can augment the area of damage. Am J Pathol. 1987 Jul;128(1):131–140.[PMC free article] [PubMed] [Google Scholar]
  • Wershil BK, Murakami T, Galli SJ. Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J Immunol. 1988 Apr 1;140(7):2356–2360. [PubMed] [Google Scholar]
  • Takeishi T, Martin TR, Katona IM, Finkelman FD, Galli SJ. Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses. J Clin Invest. 1991 Aug;88(2):598–608.[PMC free article] [PubMed] [Google Scholar]
  • Martin TR, Galli SJ, Katona IM, Drazen JM. Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J Clin Invest. 1989 Apr;83(4):1375–1383.[PMC free article] [PubMed] [Google Scholar]
  • Jacoby W, Cammarata PV, Findlay S, Pincus SH. Anaphylaxis in mast cell-deficient mice. J Invest Dermatol. 1984 Oct;83(4):302–304. [PubMed] [Google Scholar]
  • Mapp C, Hartiala J, Frick OL, Shields RL, Gold WM. Airway responsiveness to inhaled antigen, histamine, and methacholine in inbred, ragweed-sensitized dogs. Am Rev Respir Dis. 1985 Aug;132(2):292–298. [PubMed] [Google Scholar]
  • Patterson R, Harris KE. Parallel induction of IgE-mediated Ascaris antigen airway responses and increased carbachol airway reactivity in rhesus monkeys by infection with Ascaris suum. J Lab Clin Med. 1985 Sep;106(3):293–297. [PubMed] [Google Scholar]
  • Wagner EM, Kleeberger SR, Spannhake EW, Adams GK., 3rd Increased in vitro airway responsiveness in sheep following repeated exposure to antigen in vivo. J Appl Physiol (1985) 1985 Dec;59(6):1874–1878. [PubMed] [Google Scholar]
  • Michoud MC, Paré PD, Boucher R, Hogg JC. Airway responses to histamine and methocholine in Ascaris suum-allergic rhesus monkeys. J Appl Physiol Respir Environ Exerc Physiol. 1978 Dec;45(6):846–851. [PubMed] [Google Scholar]
  • Young JD, Liu CC, Butler G, Cohn ZA, Galli SJ. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9175–9179.[PMC free article] [PubMed] [Google Scholar]
  • Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature. 1990 Jul 19;346(6281):274–276. [PubMed] [Google Scholar]
  • Kips JC, Tavernier J, Pauwels RA. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):332–336. [PubMed] [Google Scholar]
  • Kay AB. "Helper" (CD4+) T cells and eosinophils in allergy and asthma. Am Rev Respir Dis. 1992 Feb;145(2 Pt 2):S22–S26. [PubMed] [Google Scholar]
Ina Sue Perlmutter Laboratory, Department of Pediatrics, Children's Hospital, Boston, Massachusetts 02115.
Ina Sue Perlmutter Laboratory, Department of Pediatrics, Children's Hospital, Boston, Massachusetts 02115.
Abstract
Mast cell-deficient mutant mice and their normal littermates were used to determine whether activation of mast cells by anti-IgE enhances airway responsiveness to bronchoactive agonists in vivo. Pulmonary conductance was used as an index of airway response as the mice were challenged with increasing intravenous doses of methacholine (Mch) or 5-hydroxytryptamine (5-HT). Mast cell activation with anti-IgE enhanced pulmonary responsiveness to Mch in both types of normal mice (P < 0.0001 by analysis of variance) but not in either genotype of mast cell-deficient mouse. Additionally, anti-IgE pretreatment of genetically mast cell-deficient W/Wv mice whose mast cell deficiency had been repaired by infusion of freshly obtained bone marrow cells or bone marrow-derived cultured mast cells from congenic normal mice led to significant (P < 0.0001) enhancement of Mch responsiveness. 5-HT responsiveness was not significantly influenced by anti-IgE pretreatment in any of the mice studied. The data support the hypothesis that IgE-mediated activation of mast cells enhances pulmonary responsiveness to cholinergic stimulation.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.